You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COVID-19 Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vaccine Hesitancy Trial (Multilevel Intervention)

Not yet recruiting
  • Vaccine Hesitancy
  • Multilevel Intervention
  • (no location specified)
Nov 30, 2023

A Study of the Effectiveness of Moderna COVID-19 Vaccine

Recruiting
  • SARS-CoV-2
  • COVID-19
  • mRNA-1273
  • Pasadena, California
    Kaiser Permanente Southern California
Jul 5, 2023

COVID-19 Trial (Recombinant variant COVID-19 vaccine (Sf9 cell), Recombinant COVID-19 vaccine (CHO cell), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant variant COVID-19 vaccine (Sf9 cell)
  • +2 more
  • (no location specified)
Mar 10, 2023

Vaccine-Preventable Diseases, COVID-19 Pandemic, Health-Related Behavior Trial (Baseline surveys, Digital Storytelling

Not yet recruiting
  • Vaccine-Preventable Diseases
  • +4 more
  • Baseline surveys
  • +2 more
  • (no location specified)
Sep 12, 2023

SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10

Recruiting
  • SARS-CoV-2 Infection
  • Placebo
  • +4 more
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Nov 7, 2023

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

Active, not recruiting
  • Coronavirus Disease (COVID-19)
  • COVID-19 Vaccine
  • Tokyo, Japan
    Moderna selected site
Jan 12, 2023

Study of the Effectiveness of The COVID-19 Vaccine

Completed
  • COVID-19
  • COVID-19 Antibody
  • Sukoharjo, Central Java, Indonesia
    Universitas Sebelas Maret Hospital
Mar 9, 2023

COVID-19 Pneumonia, Coronavirus Infections Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-08), Inactivated

Recruiting
  • COVID-19 Pneumonia
  • Coronavirus Infections
  • Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-08)
  • +2 more
  • Seha, Abu Dhab, United Arab Emirates
    Sheikh Khalifa Medical City
Jan 30, 2023

COVID-19 Trial (Recombinant variant COVID-19 vaccine(Sf9 cell))

Not yet recruiting
  • COVID-19
  • Recombinant variant COVID-19 vaccine(Sf9 cell)
  • (no location specified)
Mar 10, 2023

Anti-COVID-19 Vaccine Side Effects

Completed
  • Vaccine Adverse Reaction
  • +2 more
    • Bari, BA, Italy
      Department of Biomedical Sciences and Human Oncology - Clinica m
    Feb 20, 2023

    Covid19, Vaccine Refusal, Vaccine Hesitancy Trial in New Orleans (COVID-19 Vaccine Education at the Point of COVID-19 Testing)

    Recruiting
    • Covid19
    • +2 more
    • COVID-19 Vaccine Education at the Point of COVID-19 Testing
    • New Orleans, Louisiana
      Xavier University of Louisiana
    Dec 19, 2022

    COVID-19 Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-09), Inactivated COVID-19 vaccine (Vero cells))

    Active, not recruiting
    • COVID-19
    • Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09)
    • Inactivated COVID-19 vaccine (Vero cells)
    • Seha, Abu Dhab, United Arab Emirates
      Sheikh Khalifa Medical City
    Jan 31, 2023

    SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

    Recruiting
    • SARS-CoV-2 Infection
    • COVID-19 mRNA Vaccine (ZSVG-02-O)
    • COVID-19 Vaccine (Vero Cell) ,Inactivated
    • Dengfeng, Henan, China
    • +1 more
    Nov 6, 2023

    Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.

    Completed
    • COVID-19 Vaccine Adverse Reaction
    • COVID-19 Vaccine questionnaire
    • Damanhūr, Elbehairah, Egypt
      Rehab Hussein Werida
    May 10, 2023

    COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction Trial in Stockholm (DNA vaccine OC-007, Placebo)

    Not yet recruiting
    • COVID-19 Respiratory Infection
    • COVID-19 Vaccine Adverse Reaction
    • DNA vaccine OC-007
    • Placebo
    • Stockholm, Region Stockholm, Sweden
      Phase I Study Unit, Karolinska University Hospital
    Jan 13, 2023

    Immunogenicity of COVID-19 Vaccine in Inflammatory Bowel Disease

    Completed
    • IBD
    • Covid19 Vaccine
    • Serological Assay for SARS-CoV-2
    • Madison, Wisconsin
      University of Wisconsin
    Dec 5, 2022

    COVID-19 Trial (1 Nebulized inhalation for booster groups, 2 Nebulized inhalation for booster groups, 3 Nebulized inhalation for

    Recruiting
    • COVID-19
    • 1 Nebulized inhalation for booster groups
    • +23 more
    • Xiangxi, Hunan, China
      CDC of of Luxi County, Xiangxi Tujia and Miao Autonomous Prefect
    Oct 24, 2022

    COVID-19 Trial in Huai'an (COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell),

    Recruiting
    • COVID-19
    • COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
    • COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
    • Huai'an, Jiangsu, China
      Huaiyin Center for Disease Control and Prevention
    Jan 11, 2023

    Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell

    Recruiting
    • Hematologic Diseases
    • COVID-19 vaccine(donor)
    • COVID-19 vaccine(patient)
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Nov 8, 2022

    HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA

    Recruiting
    • HIV
    • +5 more
    • Pfizer Bivalent COVID-19 Vaccine
    • Moderna Bivalent mRNA vaccine
    • Melbourne, Victoria, Australia
      Alfred Health
    Jan 31, 2023

    Menstrual Irregularities and Abnormal Uterine Bleeding After

    Completed
    • COVID-19
    • +3 more
    • Covid-19 vaccine
    • Varese, Italy
      University of Insubria
    Oct 31, 2022

    Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy Trial in Durham (SCD-specific COVID-19 vaccination information (SCVI)

    Not yet recruiting
    • Sickle Cell Disease
    • +2 more
    • SCD-specific COVID-19 vaccination information (SCVI) video
    • Durham, North Carolina
      Duke Adult Sickle Cell Program
    Aug 17, 2023

    Understanding COVID-19 Vaccine Immunity in Tissue and Blood

    Recruiting
    • COVID-19 (Coronavirus Disease 2019)
    • No intervention
    • Palo Alto, California
      Stanford University
    Jan 10, 2023

    COVID-19 Trial in Singapore (Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation)

    Not yet recruiting
    • COVID-19
    • Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation
    • Singapore, Singapore
      National University Hospital
    Jan 29, 2023

    COVID-19 Trial (Recombinant two-component COVID-19 vaccine (CHO cell), Placebo)

    Recruiting
    • COVID-19
    • Part1:Recombinant two-component COVID-19 vaccine (CHO cell)
    • +3 more
    • Roxas City, Philippines
      The Health Centrum
    Sep 29, 2022